USES OF INTRAVENOUS IMMUNOGLOBULINES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RASI A.; ANSARIN H.; KHATAMI A.R.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Dermatology Year:2005 | Volume:8 | Issue:4 (32) Page(s): 299-306

Download Full-Text

Persian Verion

View:

2,091

Download:

Cites:

Information Journal Paper

Title

USES OF INTRAVENOUS IMMUNOGLOBULINES

Author(s)

RASI A. | ANSARIN H. | KHATAMI A.R. | Issue Writer Certificate

Keywords

INTRAVENOUS IMMUNOGLOBULINQ4

ADJUVANT THERAPYQ4

AUTOIMMUNE DISEASESQ4

Abstract

Adjuvant high dose IVIgs are being used increasingly in a range of immune-mediated and AUTOIMMUNE DISEASES. Although numerous immunomodulatory mechanisms have been suggested, the exact mechanisms of action are poorly understood. The efficacy of IVIg in certain diseases has been proven in clinical trials, in so far as IVIg is approved as the therapy of choice for Kawasaki syndrome and idiopathic thrombocytopenic purpura. IVIg treatment has been shown to be safe, without many drug-related adverse effects, including systemic immunosuppression, that are related to corticosteroids and other immunosuppressive agents. Current dermatologic uses of IVIg are increasing, which calls for adequately controlled clinical trials. This review evaluates the current published data on the use of IVIg therapy in the treatment of AUTOIMMUNE DISEASES and discusses current opinion concerning its potential immunomodulating mechanisms, the industrial preparation and safety features'of this biologic agent.

Cites

No record.

References

No record.

Cite

APA: Copy

RASI, A., ANSARIN, H., & KHATAMI, A.R.. (2005). USES OF INTRAVENOUS IMMUNOGLOBULINES. IRANIAN JOURNAL OF DERMATOLOGY, 8(4 (32)), 299-306. SID. https://sid.ir/paper/57920/en

Vancouver: Copy

RASI A., ANSARIN H., KHATAMI A.R.. USES OF INTRAVENOUS IMMUNOGLOBULINES. IRANIAN JOURNAL OF DERMATOLOGY[Internet]. 2005;8(4 (32)):299-306. Available from: https://sid.ir/paper/57920/en

IEEE: Copy

A. RASI, H. ANSARIN, and A.R. KHATAMI, “USES OF INTRAVENOUS IMMUNOGLOBULINES,” IRANIAN JOURNAL OF DERMATOLOGY, vol. 8, no. 4 (32), pp. 299–306, 2005, [Online]. Available: https://sid.ir/paper/57920/en

Related Journal Papers